Roche Holding | ROG - Выручка от реализации





Продажи Изменить Дата
AbbVie USD 15B 1.62B 2026-03
Alcon AG USD 2.69B 10M 2026-03
Almirall EUR 602.71M 55.09M 2026-06
Amgen USD 8.62B 1.28B 2026-03
AstraZeneca USD 15.38B 90M 2026-06
Bayer EUR 13.41B 1.97B 2026-03
Biogen USD 2.74B 490M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Eli Lilly USD 19.8B 500M 2026-03
Fresenius EUR 5.74B 140M 2026-03
Fresenius Medical Care EUR 4.61B 460M 2026-03
Genmab DKK 1.06B 36M 2025-12
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 8.41B 781M 2026-06
GRIFOLS EUR 1.87B 170M 2026-06
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lakefront Biotherapeutics EUR 6.5M 894.32M 2026-03
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.13B 120M 2026-03
Merck USD 16.29B 110M 2026-03
Novartis USD 14.41B 1.3B 2026-06
Orion EUR 521.6M 103.9M 2026-06
Pfizer USD 14.5B 3.08B 2026-03
Philips EUR 4.36B 450M 2026-06
Recordati EUR 681.35M 32.07M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 11.95B 710M 2026-06
UCB EUR 4.25B 764M 2025-12